Besides, the overall AUC of 0.9 (Figure 4(a)) further revealed that overexpressed NR2F6 might act as a potential biomarker to distinguish hepatoblastoma and non-cancer liver tissues with a sensitivity of 0.76 (Figure 4(b)) and a specificity of 0.89 (Figure 4(c)), suggested by the summarized ROC integrated by 440 samples. Here, NR2F6 is linked to hepatoblastoma.